Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway
- 131 Downloads
Oxymatrine extracted from Sophora flavescens Ait as a natural polyphenolic phytochemical has been demonstrated to exhibit anti-tumor effects on various cancers, including Gallbladder carcinoma (GBC). However, its underlying mechanisms of function are largely unknown in GBC cells. The present study is conducted to investigate the anti-tumor effects and the underlying mechanisms of oxymatrine on GBC cells in vitro and in vivo. The results showed that oxymatrine inhibited cell viability, metastatic ability and induced cell apoptosis in dose-dependent manners. Furthermore, we found that the expression of p-AKT, MMP-2, MMP-9 and the ratio of Bcl-2/Bax were significantly down-regulated, while the expression of PTEN was up-regulated in GBC cells. In addition, pretreatment with a specific PI3K/AKT activator (IGF-1) significantly antagonized the oxymatrine-mediated inhibition of GBC–SD cells. Subsequently, our in vivo studies showed that administration of oxymatrine induced a significant dose-dependent decrease in tumor growth. In conclusion, these findings indicated that the inhibition of cells proliferation, migration, invasion and the induction of apoptosis in response to oxymatrine in GBC cells, may function through the suppression of PTEN/PI3K/AKT pathway, which was considered as the vital signaling pathway in regulating tumorigenesis. These results suggested that oxymatrine might be a novel effective candidate as chemotherapeutic agent against GBC.
KeywordsOxymatrine Gallbladder carcinoma Invasion PTEN AKT
This study was supported by the Program for integrative medicine of Suzhou City (No. SYSD2015163).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Butler MS (2008) ChemInform abstract: natural products to drugs: natural product derived compounds in clinical trials. Cheminform 39:162–195Google Scholar
- Chen JS, Huang X, Wang Q, Huang JQ, Zhang L, Chen XL, Lei J, Cheng ZX (2013b) Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis 34:10–19CrossRefGoogle Scholar
- Dai ZJ, Gao J, Wu WY, Wang XJ, Li ZF, Kang HF, Liu XX, Ma XB (2007) Effect of matrine injections on invasion and metastasis of gastric carcinoma SGC-7901 cells in vitro. Zhong Yao Cai 30:815–819Google Scholar
- Gu XB, Yang XJ, Hua Z, Lu ZH, Zhang B, Zhu YF, Wu HY, Jiang YM, Chen HK, Pei H (2012) Effect of oxymatrine on specific cytotoxic T lymphocyte surface programmed death receptor-1 expression in patients with chronic hepatitis B. Chin Med J 125:1434–1438Google Scholar
- Jia J, Li S, Gong W, Ding J, Fang C, Quan Z (2011) Mda-7/IL-24 induces apoptosis in human GBC–SD gallbladder carcinoma cells via mitochondrial apoptotic pathway. Oncol Rep 25:195–201Google Scholar
- Lao Y (2005) Clinical study on effect of matrine injection to protect the liver function for patients with primary hepatic carcinoma after trans-artery chemo-embolization (TAE). Zhong Yao Cai 28:637–638Google Scholar
- Li M, Shen J, Wu X, Zhang B, Zhang R, Weng H, Ding Q, Tan Z, Gao G, Mu J, Yang J, Shu Y, Bao R, Ding Q, Wu W, Cao Y, Liu Y (2013) Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion. Med Oncol 30:1–8Google Scholar
- Li J, Jiang K, Zhao F (2015) Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA-29b and downregulating matrix metalloproteinase-2 expression. Mol Med Rep 12:145–151Google Scholar
- Liu F, He Y, Liang Y, Wen L, Zhu Y, Wu Y, Zhao LX, Li YS, Mao XL, Liu HY (2013a) PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinoma. Cancer Cell Int 13:1223–1227Google Scholar
- Qin X, Yin J, Zhang H (2009) Effects of oxymatrine on proliferation of HepG2 cells. China J Chin Mater Med 34:1426–1429Google Scholar
- Sun M, Cao H, Sun L, Dong S, Bian Y, Han J, Zhang L, Ren S, Hu Y, Liu C, Xu L, Liu P (2012a) Antitumor activities of kushen: literature review. Evid Based Complement Alternat Med 2012:373219Google Scholar
- Sun Q, Ma W, Gao Y, Zheng W, Zhang B, Peng Y (2012b) Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma. Afr J Tradit Complement Altern Med 9:178–188Google Scholar